Legal Opinion
Sanofi-Synthelabo v. Apotex, Inc.
Court of Appeals for the Federal Circuit
Decided December 12, 2008No. 2007-1438PublishedCited by 81 opinions
1Opinion of the Court
NEWMAN, Circuit Judge.
This suit arose in accordance with the provisions of the Hatch-Waxman Act, codified at 35 U.S.C. § 271(e) and 21 U.S.C. § 355(j). The patent at issue is United States Patent No. 4,847,265 (the '265 patent), owned by Sanofi-Synthelabo and related companies (collectively “Sanofi”), and covers the pharmaceutical product having the common name clopidogrel bisulfate and the brand name Plavix®. The product has the property of inhibiting the aggregation of blood platelets, and is used to treat or prevent blood-thrombotic events such as heart attacks and strokes. We affirm the…
2Cases cited27 opinions
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- KSR International Co. v. Teleflex Inc.Supreme Court of the United States · 2007
- Continental Can Company Usa, Inc. And Continental Pet Technologies, Inc. v. Monsanto Company, Hoover Universal, Inc. And Johnson Controls, Inc.Court of Appeals for the Federal Circuit · 1991
- Jerry F. Connell, Gary F. Burns and Conelco, Inc., Appellants/cross-Appellees v. Sears, Roebuck & Co., a Corporation, Appellee/cross-AppellantCourt of Appeals for the Federal Circuit · 1983
- Pfizer, Inc. v. Apotex, Inc.Court of Appeals for the Federal Circuit · 2007
22 more not listed; retrieve them via the Exa API.
3Cited by81 opinions
- Procter & Gamble Co. v. Teva Pharmaceuticals USA, Inc.Court of Appeals for the Federal Circuit · 2009
- Ohio Willow Wood Co. v. Alps South, LLCCourt of Appeals for the Federal Circuit · 2013
- ASTRAZENECA LP v. Apotex, Inc.Court of Appeals for the Federal Circuit · 2010
- Taurus IP, LLC v. Daimlerchrysler Corp.Court of Appeals for the Federal Circuit · 2013
- Wasica Finance GmbH v. Continental Automotive Systems, Inc.Court of Appeals for the Federal Circuit · 2017
76 more not listed; retrieve them via the Exa API.